Medinova Diagnostic Services Share Price
Sector: Healthcare Facilities
39.90 +0.20 (0.50%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
39.00
Today’s High
40.40
52 Week Low
32.10
52 Week High
51.05
Key Metrics
- Market Cap (In Cr) 39.83
- Beta 1.78
- Div. Yield (%) 0
- P/B -
- TTM P/E 20.01
- Sector P/E 22.38
- Open Price 39.4
- Prev Close 39.7
Medinova Diagnostic Services Analysis
Price Analysis
-
1 Week3.77%
-
3 Months5.08%
-
6 Month6.59%
-
YTD7.25%
-
1 Year-0.6%
Risk Meter
- 42% Low risk
- 42% Moderate risk
- 42% Balanced Risk
- 42% High risk
- 42% Extreme risk
Medinova Diagnostic Services Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 9.81
- Selling/ General/ Admin Expenses Total
- 2.57
- Depreciation/ Amortization
- 0.14
- Other Operating Expenses Total
- 3.6
- Total Operating Expense
- 6.96
- Operating Income
- 2.85
- Net Income Before Taxes
- 2.5
- Net Income
- 1.9
- Diluted Normalized EPS
- 1.89
- Period
- 2025
- Total Assets
- 6.93
- Total Liabilities
- 8.18
- Total Equity
- -1.25
- Tangible Book Valueper Share Common Eq
- -1.28
- Period
- 2025
- Cashfrom Operating Activities
- 2.52
- Cashfrom Investing Activities
- -1.9
- Cashfrom Financing Activities
- -0.63
- Net Changein Cash
- -0.01
- Period
- 2024
- Total Revenue
- 10.17
- Selling/ General/ Admin Expenses Total
- 2.4
- Depreciation/ Amortization
- 0.13
- Other Operating Expenses Total
- 3.98
- Total Operating Expense
- 7.51
- Operating Income
- 2.65
- Net Income Before Taxes
- 2.28
- Net Income
- 2
- Diluted Normalized EPS
- 2
- Period
- 2024
- Total Assets
- 5.38
- Total Liabilities
- 8.51
- Total Equity
- -3.12
- Tangible Book Valueper Share Common Eq
- -3.17
- Period
- 2024
- Cashfrom Operating Activities
- 2.67
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- -1.32
- Net Changein Cash
- 1.14
- Period
- 2023
- Total Revenue
- 9.99
- Selling/ General/ Admin Expenses Total
- 2.38
- Depreciation/ Amortization
- 0.33
- Other Operating Expenses Total
- 3.72
- Total Operating Expense
- 7.72
- Operating Income
- 2.27
- Net Income Before Taxes
- 1.9
- Net Income
- 1.67
- Diluted Normalized EPS
- 1.67
- Period
- 2023
- Total Assets
- 4.48
- Total Liabilities
- 9.61
- Total Equity
- -5.14
- Tangible Book Valueper Share Common Eq
- -5.15
- Period
- 2023
- Cashfrom Operating Activities
- 1.42
- Cashfrom Investing Activities
- -0.34
- Cashfrom Financing Activities
- -0.85
- Net Changein Cash
- 0.23
- Period
- 2022
- Total Revenue
- 13.2
- Selling/ General/ Admin Expenses Total
- 3.72
- Depreciation/ Amortization
- 0.55
- Other Operating Expenses Total
- 3.23
- Total Operating Expense
- 10.04
- Operating Income
- 3.16
- Net Income Before Taxes
- 2.8
- Net Income
- 2.27
- Diluted Normalized EPS
- 2.27
- Period
- 2022
- Total Assets
- 4.44
- Total Liabilities
- 11.25
- Total Equity
- -6.81
- Tangible Book Valueper Share Common Eq
- -6.83
- Period
- 2022
- Cashfrom Operating Activities
- 1.35
- Cashfrom Investing Activities
- -1.84
- Cashfrom Financing Activities
- 0.31
- Net Changein Cash
- -0.17
- Period
- 2021
- Total Revenue
- 12.74
- Selling/ General/ Admin Expenses Total
- 5.07
- Depreciation/ Amortization
- 0.72
- Other Operating Expenses Total
- 3.08
- Total Operating Expense
- 10.45
- Operating Income
- 2.29
- Net Income Before Taxes
- 1.96
- Net Income
- 2.02
- Diluted Normalized EPS
- 2.03
- Period
- 2021
- Total Assets
- 4.37
- Total Liabilities
- 11.57
- Total Equity
- -7.2
- Tangible Book Valueper Share Common Eq
- -7.21
- Period
- 2021
- Cashfrom Operating Activities
- 1.93
- Cashfrom Investing Activities
- -0.31
- Cashfrom Financing Activities
- -1.37
- Net Changein Cash
- 0.25
- Period
- 2020
- Total Revenue
- 7.45
- Selling/ General/ Admin Expenses Total
- 1.92
- Depreciation/ Amortization
- 0.95
- Other Operating Expenses Total
- 3.25
- Total Operating Expense
- 7.2
- Operating Income
- 0.24
- Net Income Before Taxes
- -0.28
- Net Income
- -0.26
- Diluted Normalized EPS
- -0.26
- Period
- 2020
- Total Assets
- 4.06
- Total Liabilities
- 13.23
- Total Equity
- -9.17
- Tangible Book Valueper Share Common Eq
- -9.19
- Period
- 2020
- Cashfrom Operating Activities
- 1.24
- Cashfrom Investing Activities
- -0.02
- Cashfrom Financing Activities
- -1.07
- Net Changein Cash
- 0.15
- Period
- 2025-03-31
- Total Revenue
- 2.51
- Selling/ General/ Admin Expenses Total
- 0.63
- Depreciation/ Amortization
- 0.04
- Other Operating Expenses Total
- 0.92
- Total Operating Expense
- 1.7
- Operating Income
- 0.81
- Net Income Before Taxes
- 0.76
- Net Income
- 0.6
- Diluted Normalized EPS
- 0.6
- Period
- 2025-03-31
- Total Assets
- 6.93
- Total Liabilities
- 8.18
- Total Equity
- -1.25
- Tangible Book Valueper Share Common Eq
- -1.28
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 2.52
- Cashfrom Investing Activities
- -1.9
- Cashfrom Financing Activities
- -0.63
- Net Changein Cash
- -0.01
- Period
- 2024-12-31
- Total Revenue
- 2.25
- Selling/ General/ Admin Expenses Total
- 0.66
- Depreciation/ Amortization
- 0.04
- Other Operating Expenses Total
- 0.79
- Total Operating Expense
- 1.63
- Operating Income
- 0.62
- Net Income Before Taxes
- 0.52
- Net Income
- 0.38
- Diluted Normalized EPS
- 0.38
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 2.56
- Selling/ General/ Admin Expenses Total
- 0.66
- Depreciation/ Amortization
- 0.04
- Other Operating Expenses Total
- 0.93
- Total Operating Expense
- 1.8
- Operating Income
- 0.76
- Net Income Before Taxes
- 0.66
- Net Income
- 0.5
- Diluted Normalized EPS
- 0.5
- Period
- 2024-09-30
- Total Assets
- 6.38
- Total Liabilities
- 8.59
- Total Equity
- -2.2
- Tangible Book Valueper Share Common Eq
- -2.25
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 1.16
- Cashfrom Investing Activities
- -0.32
- Cashfrom Financing Activities
- -0.27
- Net Changein Cash
- 0.57
- Period
- 2024-06-30
- Total Revenue
- 2.49
- Selling/ General/ Admin Expenses Total
- 0.62
- Depreciation/ Amortization
- 0.03
- Other Operating Expenses Total
- 0.97
- Total Operating Expense
- 1.83
- Operating Income
- 0.66
- Net Income Before Taxes
- 0.55
- Net Income
- 0.42
- Diluted Normalized EPS
- 0.42
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 2.49
- Selling/ General/ Admin Expenses Total
- 0.57
- Depreciation/ Amortization
- 0.03
- Other Operating Expenses Total
- 0.95
- Total Operating Expense
- 1.78
- Operating Income
- 0.71
- Net Income Before Taxes
- 0.7
- Net Income
- 0.6
- Diluted Normalized EPS
- 0.6
- Period
- 2024-03-31
- Total Assets
- 5.38
- Total Liabilities
- 8.51
- Total Equity
- -3.12
- Tangible Book Valueper Share Common Eq
- -3.17
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 2.67
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- -1.32
- Net Changein Cash
- 1.14
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Medinova Diagnostic Services Technical
Moving Average
SMA
- 5 Day38.76
- 10 Day38.74
- 20 Day38.86
- 50 Day39.66
- 100 Day38.42
- 300 Day38.7
Medinova Diagnostic Services Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aspira Pathlab & Diagnostics
- 57
- 1
- 1.79
- 106.78
- 25
- 58.67
- N G Industries
- 156
- 0.85
- 0.55
- 205.5
- 145
- 52
- Medinova Diagnostic Services
- 39.9
- 0.2
- 0.5
- 51.05
- 32.1
- 39.83
- Tejnaksh Healthcare
- 19.2
- 0.27
- 1.43
- 29.5
- 18.79
- 39
- Samsrita Labs
- 20.71
- -0.42
- -1.99
- 32.36
- 12.19
- 30.67
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aspira Pathlab & Diagnostics
- 28.43
- 4.74
- 9.82
- 6.04
- N G Industries
- 6.72
- 1.35
- 19.12
- 29.49
- Medinova Diagnostic Services
- 21.01
- -
- -
- 17.61
- Tejnaksh Healthcare
- 16.46
- 1.48
- 10.23
- 17.36
- Samsrita Labs
- -
- 2.59
- -0.79
- -852.97
Medinova Diagnostic Services Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 03-May-25
- Audited Results
- 30-Jan-25
- Quarterly Results
- 29-Oct-24
- Quarterly Results
- 30-Jul-24
- Quarterly Results
- 26-Apr-24
- Audited Results
- 31-Jan-24
- Quarterly Results
- 02-Nov-23
- Quarterly Results
- 28-Jul-23
- Quarterly Results
- 17-May-23
- Audited Results
- 01-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 25-Apr-25
- 25-Mar-25
- COM
- 03-Sept-24
- 09-Aug-24
- AGM
- 18-Sept-23
- 17-May-23
- AGM
- 04-Aug-21
- 09-Jul-21
- AGM
- 19-Jul-21
- 14-Jun-21
- POM



